SC
TEVA icon

SouthState Corp’s Teva Pharmaceuticals TEVA Stock Holding History

SouthState Corp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-59
Closed -$989 – 1594
2025
Q2 		$989 Buy
+59
New +$952 ﹤0.01% 1266
2025
Q1 		– Sell
-1,061
Closed -$23.4K – 1732
2024
Q4 		$23.4K Buy
+1,061
New +$19.3K ﹤0.01% 417
2016
Q1 		– Sell
-5,547
Closed -$365K – 217
2015
Q4 		$365K Sell
5,547
-1,070
-16% -$66.1K 0.06% 169
2015
Q3 		$374K Sell
6,617
-100
-1% -$6.48K 0.06% 179
2015
Q2 		$397K Sell
6,717
-92
-1% -$5.67K 0.06% 179
2015
Q1 		$424K Buy
6,809
+599
+10% +$34.8K 0.06% 180
2014
Q4 		$357K Sell
6,210
-100
-2% -$5.57K 0.06% 189
2014
Q3 		$340K Sell
6,310
-550
-8% -$29.1K 0.05% 206
2014
Q2 		$360K Buy
6,860
+100
+1% +$5.11K 0.06% 195
2014
Q1 		$357K Buy
6,760
+347
+5% +$16K 0.06% 198
2013
Q4 		$257K Sell
6,413
-7,054
-52% -$278K 0.04% 221
2013
Q3 		$508K Sell
13,467
-33,350
-71% -$1.3M 0.09% 161
2013
Q2 		$1.83M Buy
+46,817
New +$1.82M 0.39% 81

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

SouthState Corp's TEVA Position: Q3 2025 in Review

SouthState Corp sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 59 shares — an estimated $989 sold.

SouthState Corp first reported a position in TEVA in Q2 2013 and held it in 13 quarters. The position peaked at $1.83M in Q2 2013. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • SouthState Corp reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • SouthState Corp sold 59 Teva Pharmaceuticals shares in Q3 2025, an estimated $989.
  • SouthState Corp first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 13 quarters.
  • SouthState Corp's Teva Pharmaceuticals position peaked at $1.83M in Q2 2013.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on SouthState Corp's 13F filing for Q3 2025, filed 5 Nov 2025.